NLRP3 and polycystic ovary syndrome: 2021). Li et al. showed that miR-1224-5p was able to attenuate the symptoms of PCOS mice through inhibiting the activation of NLRP3 inflammasome via targeting FOXO1 (Li et al. 2021).